BioCentury | Oct 12, 2015
Company News

CARgenix, Sorrento deal

...In August, Sorrento’s TNK Therapeutics Inc. subsidiary purchased CARgenix for $100 plus $6 million in TNK...
...T cell immunotherapy programs in solid tumors and HIV infection and the underlying CAR-T technology. CARgenix Holdings LLC...
Items per page:
1 - 1 of 1
BioCentury | Oct 12, 2015
Company News

CARgenix, Sorrento deal

...In August, Sorrento’s TNK Therapeutics Inc. subsidiary purchased CARgenix for $100 plus $6 million in TNK...
...T cell immunotherapy programs in solid tumors and HIV infection and the underlying CAR-T technology. CARgenix Holdings LLC...
Items per page:
1 - 1 of 1